Arcadia Biosciences (RKDA) Tops Q1 EPS by 83c, Revenues Miss; Reiterates FY20 Revenue Guidance Above Consensus

Go back to Arcadia Biosciences (RKDA) Tops Q1 EPS by 83c, Revenues Miss; Reiterates FY20 Revenue Guidance Above Consensus

Arcadia Biosciences Announces First-Quarter 2020 Financial Results and Business Highlights

May 13, 2020 4:05 PM EDT

DAVIS, Calif., May 13, 2020 /PRNewswire/ -- Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of crops and food ingredients, today released its financial and business results for the first quarter of 2020.

... More